findmyKOL
Clinical trialNCT06710548RecruitingInterventional

REVITALIZE: RCT to Reduce Fatigue in Adults With Ovarian Cancer on PARP Inhibitors

SponsorDana-Farber Cancer InstituteEnrollment240Advanced Ovarian CarcinomaFallopian Tube CarcinomaFatigue Related to Cancer TreatmentFatigue in Cancer SurvivorsOvarian CancerPARP Inhibitor+1 more conditions
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of Colorado Cancer Center-Anschutz

    Aurora, Colorado, United States

    Carolyn Lefkowits, MD, MPH, MS
    Recruiting
  • University of Colorado Boulder

    Boulder, Colorado, United States

    Joanna J Arch, PhD
    Recruiting
  • Beth Israel Deaconess Medical Center

    Boston, Massachusetts, United States

    Recruiting
  • Dana-Farber Cancer Institute

    Boston, Massachusetts, United States

    Alexi Wright, MD, MPH
    Recruiting
  • Massachusetts General Hospital-Cancer Center

    Boston, Massachusetts, United States

    Recruiting
  • Duke Cancer Center

    Durham, North Carolina, United States

    Laura Havrilesky, MD, MHSc
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
17 Mar 2025
Primary completion
31 Dec 2028
Completion
31 Jan 2029
Last update posted
13 Apr 2026
Registered enrollment
240
Registry id
NCT06710548
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.